201 related articles for article (PubMed ID: 27577957)
21. Adenosine A(3) receptor-mediated potentiation of mucociliary transport and epithelial ciliary motility.
Taira M; Tamaoki J; Nishimura K; Nakata J; Kondo M; Takemura H; Nagai A
Am J Physiol Lung Cell Mol Physiol; 2002 Mar; 282(3):L556-62. PubMed ID: 11839552
[TBL] [Abstract][Full Text] [Related]
22. Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor.
Wen LT; Knowles AF
Br J Pharmacol; 2003 Nov; 140(6):1009-18. PubMed ID: 14530217
[TBL] [Abstract][Full Text] [Related]
23. Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation.
Sandhu H; Cooper S; Hussain A; Mee C; Maddock H
Eur J Pharmacol; 2017 Nov; 814():95-105. PubMed ID: 28811127
[TBL] [Abstract][Full Text] [Related]
24. Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release.
Ezeamuzie CI; Philips E
Br J Pharmacol; 1999 May; 127(1):188-94. PubMed ID: 10369472
[TBL] [Abstract][Full Text] [Related]
25. Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis.
Appel E; Kazimirsky G; Ashkenazi E; Kim SG; Jacobson KA; Brodie C
J Mol Neurosci; 2001 Dec; 17(3):285-92. PubMed ID: 11859924
[TBL] [Abstract][Full Text] [Related]
26. A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.
Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Leung E; Maclennan S; Borea PA
J Biol Chem; 2005 May; 280(20):19516-26. PubMed ID: 15774470
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells.
Nakashima KI; Iwao K; Inoue T; Haga A; Tsutsumi T; Mochita MI; Fujimoto T; Tanihara H
Exp Eye Res; 2018 May; 170():160-168. PubMed ID: 29486164
[TBL] [Abstract][Full Text] [Related]
28. A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia.
Stambaugh K; Jacobson KA; Jiang JL; Liang BT
Am J Physiol; 1997 Jul; 273(1 Pt 2):H501-5. PubMed ID: 9249524
[TBL] [Abstract][Full Text] [Related]
29. Identification of the A3 adenosine receptor in rat retinal ganglion cells.
Zhang M; Budak MT; Lu W; Khurana TS; Zhang X; Laties AM; Mitchell CH
Mol Vis; 2006 Aug; 12():937-48. PubMed ID: 16943766
[TBL] [Abstract][Full Text] [Related]
30. Involvement of A
Maugeri G; D'Amico AG; Federico C; Saccone S; Giunta S; Cavallaro S; D'Agata V
J Mol Neurosci; 2019 Sep; 69(1):166-176. PubMed ID: 31166001
[TBL] [Abstract][Full Text] [Related]
31. Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes.
Safran N; Shneyvays V; Balas N; Jacobson KA; Nawrath H; Shainberg A
Mol Cell Biochem; 2001 Jan; 217(1-2):143-52. PubMed ID: 11269659
[TBL] [Abstract][Full Text] [Related]
32. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.
Auchampach JA; Ge ZD; Wan TC; Moore J; Gross GJ
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H607-13. PubMed ID: 12689858
[TBL] [Abstract][Full Text] [Related]
33. Adenosine A₂A and A₃ receptors are involved in the human endothelial progenitor cells migration.
Fernandez P; Jara C; Aguilera V; Caviedes L; Diaz F; Radojkovic C; Veas C; Lamperti L; Escudero C; Aguayo C
J Cardiovasc Pharmacol; 2012 May; 59(5):397-404. PubMed ID: 22217884
[TBL] [Abstract][Full Text] [Related]
34. A3 adenosine receptors regulate Cl- channels of nonpigmented ciliary epithelial cells.
Mitchell CH; Peterson-Yantorno K; Carré DA; McGlinn AM; Coca-Prados M; Stone RA; Civan MM
Am J Physiol; 1999 Mar; 276(3):C659-66. PubMed ID: 10069993
[TBL] [Abstract][Full Text] [Related]
35. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
Fishman P; Bar-Yehuda S; Barer F; Madi L; Multani AS; Pathak S
Exp Cell Res; 2001 Oct; 269(2):230-6. PubMed ID: 11570815
[TBL] [Abstract][Full Text] [Related]
36. Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells.
Reshkin SJ; Guerra L; Bagorda A; Debellis L; Cardone R; Li AH; Jacobson KA; Casavola V
J Membr Biol; 2000 Nov; 178(2):103-13. PubMed ID: 11083899
[TBL] [Abstract][Full Text] [Related]
37. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
[TBL] [Abstract][Full Text] [Related]
38. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
[TBL] [Abstract][Full Text] [Related]
39. Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors.
Varani K; Cacciari B; Baraldi PG; Dionisotti S; Ongini E; Borea PA
Life Sci; 1998; 63(5):PL 81-7. PubMed ID: 9714428
[TBL] [Abstract][Full Text] [Related]
40. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G
Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
